<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230821059210N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-24</date_registration>
      <primary_sponsor>Jahrom University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of leech therapy on the healing period of psoriasis</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effect of leech therapy on the severity and extent of psoriasis lesions compared to conventional medical treatments in psoriasis patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72501</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After going to the departments of both hospitals and getting the list of patients from them, the patients will be contacted and interested people will be registered. Then, from the obtained list, 60 people will be randomly selected into the random number table, and with the help of the Random Number Generator software, out of 60 people (numbers 1-60), 30 people will be randomly assigned to the intervention group, Blinding description: 1- The statistical expert will be unaware of the intervention and control group. He will not be told whether the data is from the intervention or control group. Rather, only the groups will be marked with numbers 1 and 2 or with A-B, so only the researcher knows and he can interpret the results.
2- The nurses providing routine care and the person collecting data at the end of the study will also be blinded. That is, they will not know which patient was in the intervention group and which patient was in the control group. Patients are given codes and only the researcher knows these codes.</study_design>
      <phase>N/A</phase>
      <hc_freetext>psoriasis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The amount of PASI will be checked before the start of the study. Then, for 5 weeks, with a time interval of 7 days, it will be done by placing 10 leeches in the affected area. Before using the leech, the leech will be kept in non-chlorinated water for 24 hours, and before sticking the leech, the target area will be washed with water and odorless soap. Then, wearing gloves, the leech will be removed. In order to prevent the irritation and irritation of the leech. At first, 10 leeches are placed in the infected areas and the leech treated area is observed and examined for 2 minutes (to check that the leech sticks and sucks blood). If the leech is able to stick and no blood sucking, with a needle, a small incision will be made in the area and the leech will be placed on that area. Then a wet gauze or a transparent plastic cup will be placed on it to provide moisture to the leech's body and prevent the leech from moving. During the leech treatment, the patient will be checked for bleeding, sensitivity, removal of the leech, movement and vital signs of the patient. After sucking the blood by the leech, the leech will either be removed by itself or it can be removed by pouring a few drops of alcohol or betadine. and in order to prevent the possible transmission of infection by leech, it should be destroyed by pouring alcohol. After each leech treatment session, the patient will be checked for the amount of bleeding and stabilization of vital signs, and if there is no problem, he will be discharged. Before the start of the study and after the end of leprosy therapy, the PASI level of the patients in both groups will be checked. It is worth noting that the patients will receive common psoriasis treatments during the study. Intervention 2: Control group: They receive common and standard psoriasis treatments, and before and after the intervention in the intervention group, a checklist to determine the severity and extent of psoriasis is completed for them.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after de-identifying individuals

When:
The access period starts 6 months after the results are published

To whom:
It will be available only to researchers working in academic and scientific institutions

Conditions:
Send the request to the responsible author's email, and if necessary, the information will be available for meta-analysis

Where to obtain:
09177924361
Mohsen fasele

How to obtain:
Send the request to the responsible author's email, and if necessary, the information will be available for meta-analysis

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohsen fasele</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Jahrom Motahari Street. University campus site. nursing school</address>
        <city>jahrom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7414846199</zip>
        <telephone>0098 71 5433001</telephone>
        <email>m.fasele@jums.ac.ir</email>
        <affiliation>Jahrom University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohsen fasele</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Jahrom Motahari Street. University campus site. nursing school</address>
        <city>Jahrom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7414846199</zip>
        <telephone>0098 71 5434001</telephone>
        <email>m.fasele@jums.ac.ir</email>
        <affiliation>Jahrom University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>age 20-60,
Absence of other skin disorders
Having symptoms of psoriasis
Insensitivity to leech</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>20 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Failure to attend meetings regularly
Failure to follow the treatment process
Pregnancy and breastfeeding
Not using vitamins K, E, C, herbal supplements such as garlic, ginger, ginkgo, ginseng compounds, aspirin, dipyridamole, clopidogrel, heparin, warfarin and non-steroidal anti-inflammatory drugs.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>psoriasis</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>L40.0</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The amount of PASI will be checked before the start of the study. Then, for 5 weeks, with a time interval of 7 days, it will be done by placing 10 leeches in the affected area. Before using the leech, the leech will be kept in non-chlorinated water for 24 hours, and before sticking the leech, the target area will be washed with water and odorless soap. Then, wearing gloves, the leech will be removed. In order to prevent the irritation and irritation of the leech. At first, 10 leeches are placed in the infected areas and the leech treated area is observed and examined for 2 minutes (to check that the leech sticks and sucks blood). If the leech is able to stick and no blood sucking, with a needle, a small incision will be made in the area and the leech will be placed on that area. Then a wet gauze or a transparent plastic cup will be placed on it to provide moisture to the leech's body and prevent the leech from moving. During the leech treatment, the patient will be checked for bleeding, sensitivity, removal of the leech, movement and vital signs of the patient. After sucking the blood by the leech, the leech will either be removed by itself or it can be removed by pouring a few drops of alcohol or betadine. and in order to prevent the possible transmission of infection by leech, it should be destroyed by pouring alcohol. After each leech treatment session, the patient will be checked for the amount of bleeding and stabilization of vital signs, and if there is no problem, he will be discharged. Before the start of the study and after the end of leprosy therapy, the PASI level of the patients in both groups will be checked. It is worth noting that the patients will receive common psoriasis treatments during the study.</i_keyword>
      <i_keyword>Control group: They receive common and standard psoriasis treatments, and before and after the intervention in the intervention group, a checklist to determine the severity and extent of psoriasis is completed for them.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Severity and extent of psoriasis. Timepoint: Before and after the intervention in both intervention and control groups. Method of measurement: Before and after the intervention by the index of the extent and severity of psoriasis by a specific checklist Psoriasis Area Severity Index (PASI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Jahrom University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-07-29</approval_date>
        <contact_name>Ethics Committee of Jahrom University of Medical Sciences</contact_name>
        <contact_address>motahari street jahrom Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
